Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2025 ,inter alia, to consider and approve 1. The withdrawal of the proposed preferential issue which was announced by the Company on December 26, 2024; 2. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 3. The day, date, time and venue for Extra-Ordinary General Meeting of the Company; 4. The notice for Extra-Ordinary General Meeting (EOGM) of the Company; 5. To fix the date for book closure (Register of Member); 6. To appoint Mr. Nuren Lodaya Practicing Company Secretary (Membership No. 60128), proprietor of M/s. Nuren Lodaya & Associates. as Scrutinizer for conducting e-voting and poll process for General Meeting of the Company; 7. To transact other incidental and ancillary matters as may be decided by the Board with the permission of Chairperson.